Lambermont M, Toussaint P, Vandevelde L, Muyle F, Wybran J
Rev Med Brux. 1989 Apr;10(4):138-40.
In order to eliminate the risk of transmission of infectious diseases and of alloimmunisation, a pre-deposited autologous blood program for elective surgery has been started at the Erasmus Hospital. In 8 months, 51 patients have given 111 units of packed red cells and 111 units of fresh plasma. Two vasovagal reactions were observed. Four patients were withdrawn from the program in view of a hematocrit decreasing below 34%. Out of these 51 patients, 27 (53%) were transfused with only autologous blood. The autologous blood not distributed to these patients was given to other patients (10% of packed red cells and 24% of plasma). This pre-deposited autologous program has allowed to operate more than 50% of patients, undergoing elective surgery, only with autologous blood and to save homologous blood. The pre-deposited blood appears to be an interesting tool in transfusion safety and in the reduction of blood demand.
为消除传染病传播和同种免疫的风险，伊拉斯谟医院已启动一项针对择期手术的预存自体血计划。在8个月内，51名患者捐献了111单位的浓缩红细胞和111单位的新鲜血浆。观察到两例血管迷走神经反应。鉴于血细胞比容降至34%以下，4名患者退出了该计划。在这51名患者中，27名（53%）仅接受了自体血输血。未分配给这些患者的自体血输给了其他患者（10%的浓缩红细胞和24%的血浆）。这项预存自体血计划使超过50%接受择期手术的患者仅使用自体血进行手术，并节省了异体血。预存血液似乎是提高输血安全性和减少血液需求的一个有效手段。
